 |
|
|
 |
|
Rationale:
- Interventionalist-radiologists can utilize diagnostic imaging to locate, biopsy, and aspirate deep collections or masses for
diagnostic purposes as well as for therapeutic drainage without having to use a surgical incision. However, surgeons can macroscopically
visualize an infected area and perform debridement as well as drainage.
- Early diagnosis and definitive treatment may save limbs and improve survival; however, a delay in diagnosis and treatment
of necrotizing fasciitis increases mortality.
- Patients with necrotizing fasciitis or gas gangrene do not respond to antibiotics alone, and debridement of devitalized tissue
is necessary.
|
|
Evidence:
- Interventionalist-radiologists can obtain diagnostic material from deep locations through a thin needle (55).
- Surgical inspection of the deep tissues through a small incision allows evaluation of the condition of the fascia and viability
of underlying musculature (35). Tissue biopsy specimens can be obtained for Gram stain and culture.
- Diagnostic incisions can be extended to perform radical debridement should macroscopic evidence of a necrotizing infection
be present (35).
- Frozen section for histopathology has been recommended in the past (39; 56). Surgical exploration of the infected area provides macroscopic evidence of necrotizing fasciitis without the need for a
pathologist to examine the tissue microscopically. Macroscopic signs include a malodorous or “dishwater” drainage, with thrombosed
vessels and a positive “finger test,” which refers to a lack of resistance to finger dissection in normally adherent tissues
(35).
|
|
Comments:
- Diagnostic exploration determines the correct anatomic diagnosis, often yields an etiologic agent, and provides urgent treatment.
- Staphylococcal infections are frequently associated with abscesses. In one study, 73% of abscesses were caused by MRSA strains
containing PVL, whereas 23% were caused by non-PVL-containing strains (57).
|
| FAQs |
|
|
|
Dennis L. Stevens, PhD, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Lawrence J. Eron, MD, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|